LEADER 01940nam  2200613   450 
001 9910137427103321
005 20230808212952.0
010   $a1-118-84983-3
010   $a1-118-84982-5
035   $a(CKB)3710000000538850
035   $a(EBL)4205788
035   $a(SSID)ssj0001593321
035   $a(PQKBManifestationID)16290456
035   $a(PQKBTitleCode)TC0001593321
035   $a(PQKBWorkID)12804274
035   $a(PQKB)10138263
035   $a(PQKBManifestationID)15248384
035   $a(PQKBWorkID)13272641
035   $a(PQKB)21051910
035   $a(MiAaPQ)EBC4205788
035   $a(DLC)  2015033795
035   $a(Au-PeEL)EBL4205788
035   $a(CaPaEBR)ebr11136031
035   $a(CaONFJC)MIL881836
035   $a(OCoLC)935251558
035   $a(EXLCZ)993710000000538850
100   $a20160113h20162016  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aHuman drug targets $ea compendium for pharmaceutical discovery /$fEdward D. Zanders
210  1$aWest Sussex, England :$cWiley Blackwell,$d2016.
210  4$dİ2016
215   $a1 online resource (796 p.)
300   $aDescription based upon print version of record.
311   $a1-118-84984-1 
311   $a1-118-84985-X 
320   $aIncludes bibliographical references.
327   $aOverview of the drug target compendium -- Cell surface and secreted proteins -- Enzymes, part 1 -- Enzymes, part 2 -- Remaining annotated entries grouped by subcellular location -- Non-coding RNAs.
606   $aDrug targeting
606   $aDrug development
615  0$aDrug targeting.
615  0$aDrug development.
676   $a615.1/9
700   $aZanders$b Edward D.$0511858
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910137427103321
996   $aHuman drug targets$92044002
997   $aUNINA